Our network meta-analysis, Placebo-Referenced Class-Level Treatment Effects on Chronic Kidney Disease Progression in Patients With Diabetes, has been published in Endocrinology, Diabetes & Metabolism (Wiley)
compounding pharmacies and undergoes rigorous third-party testing for purity and potency
These environmental signals, along with possible metabolic reprogramming secondary to G6PD-d, could be enough to promote proatherogenic exTreg differentiation
The researchers believed this change was likely due to differences in production techniques, crop yields, strain differences and growth substrate materials
Abstract available on PubMed: PubMed Last Updated: August 29, 2025 Originally Published: August 28, 2025
niruri (freeze-dried 2% aqueous extract) or a placebo three times daily for three months